the studi investig util time 18 ffdg petct evalu residu recurr metastat hnc patient treat definit intens modul radiat therapi imrt without chemotherapi plan 18 ffdg petct the incid time locoregion recurr distant metastat diseas new primari malign death were evalu 261 patient retrospect find were classifi base patholog clinic followup sensit specif accuraci posit predict valu negat predict valu fdg petct were determin overal well time each 18 ffdg petct the overal accuraci 18 ffdg pet detect residu recurr malign metastat diseas 964 those whom cancer recur local 57 were identifi base physic examin other imag find 43 were identifi initi 18 ffdg petct surveil imag when diseas evid clinic 18 ffdg petct has high diagnost capabl detect residu recurr malign malign metastat diseas patient hnc follow imrt concurr chemotherapi support 18 fdg petct use evalu patient recurr malign postimrt period even without clinic evid diseas

Benjamin L. Franc

Christi DeLemos

Christopher Jones

<sup>18</sup>F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck

About this journal

Journal profile

Meet the editorial board

Editor spotlight

Find out more

This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.

Abstracting and Indexing

Journal of Oral Oncology

Journal of Oral Oncology

Table of Contents

Table of Contents: 2015

¹⁸F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck

Journal of Oral Oncology

Table of Contents

Table of Contents: 2015

18F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck

¹⁸F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck